Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL592867 | 1.00 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL19385435 | 1.00 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL11694103 | 1.00 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL4514648 | 1.00 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL4517239 | 1.00 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL1784070 | 1.00 | — | — | |
| SCHEMBL335804 | 1.00 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL8139520 | 1.00 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL4219652 | 1.00 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL597810 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 214 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114315551-B | Compound and preparation method and application thereof | 中国林业科学研究院森林生态环境与自然保护研究所 | 2023-09-15 | — | — | CN | claimed |
| CN-115594571-A | Preparation method of single-chain alkyl keto acid vesicle | 河南中医药大学（CN） | 2023-01-13 | — | — | CN | claimed |
| CN-114249326-B | Method for preparing sub-nano silicon-carbon composite material by liquid phase method | 盐城工学院 | 2022-07-22 | — | — | CN | claimed |
| CN-114315551-A | Compound and preparation method and application thereof | 中国林业科学研究院森林生态环境与自然保护研究所 | 2022-04-12 | — | — | CN | claimed |
| CN-114249326-A | Method for preparing sub-nano silicon-carbon composite material by liquid phase method | 盐城工学院 | 2022-03-29 | — | — | CN | claimed |
| US-20260102348-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | FUJIFILM CORPORATION (JP) | 2026-04-16 | — | — | US | disclosed |
| US-12508226-B2 | Lipid composition | FUJIFILM CORPORATION (JP) | 2025-12-30 | — | — | US | disclosed |
| US-20250249123-A1 | LIPIDS AND COMPOSITIONS THEREOF | GENERATION BIO CO. | 2025-08-07 | — | — | US | disclosed |
| US-12370143-B2 | Compound or salt thereof and lipid particles | FUJIFILM CORPORATION (JP) | 2025-07-29 | — | — | US | disclosed |
| EP-4328309-B1 | LIPID COMPOSITION | FUJIFILM CORP (JP) | 2025-07-02 | — | — | EP | disclosed |
| CN-120202208-A | Oligonucleotides comprising lipophilic monomers and their use in non-hepatic delivery | 上海拓界生物医药科技有限公司 | 2025-06-24 | — | — | CN | disclosed |
| CN-120091992-A | Cationic lipids and methods of making the same | 三养控股公司 | 2025-06-03 | — | — | CN | disclosed |
| CN-1050380-A | New substituted alkyl piperidines and as the application of cholesterol synthesis inhibitor | MERRELL DOW PHARMA (US) | 1991-04-03 | — | — | CN | disclosed |
| US-4611071-A | Metal alkyl process | ETHYL CORPORATION (US) | 1986-09-09 | — | — | US | disclosed |
| US-4411903-A | 4-[(Monosubstituted-alkyl)amino]benzoic acids and analogs as hypolipidemic and antiatherosclerotic agents | AMERICAN CYANAMID COMPANY (US) | 1983-10-25 | — | — | US | disclosed |
| US-4311846-A | 4-[(Monosubstituted-alkyl) amino]benzoic acids and analogs as hypolipidemic and antiatherosclerotic agents | AMERICAN CYANAMID COMPANY (US) | 1982-01-19 | — | — | US | disclosed |
| US-4245097-A | 4-[(Monosubstituted-alkyl) amino] benzoic acids and analogs as hypolipidemic and antiatherosclerotic agents | AMERICAN CYANAMID COMPANY (US) | 1981-01-13 | — | — | US | disclosed |
| US-4233296-A | STEROIDS HAVING PROGESTOMIMETIC PROPERTIES | ROUSSEL UCLAF (FR) | 1980-11-11 | — | — | US | disclosed |
| EP-0003663-A2 | Amino-substituted phenyl and heteroaryl compounds, process for their preparation and pharmaceutical compositions containing them | AMERICAN CYANAMID COMPANY (US) | 1979-08-22 | — | — | EP | disclosed |
| US-4147695-A | 11β-Substituted-Δ9 -steroids | ROUSSEL UCLAF (FR) | 1979-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12370143-B2 | Compound or salt thereof and lipid particles | NR1H3, NR1H2, LDLR | TSHR 999/4885THRB 2183/4885DNM1 1564/4885 |
| US-20260102348-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | LDLR, NR1H3, NR1H2 | TSHR 1103/4885THRB 1305/4885DNM1 1101/4885 |
| US-20250249123-A1 | LIPIDS AND COMPOSITIONS THEREOF | C1R, LIPG, LRBA | TSHR 2035/4885THRB 1569/4885DNM1 1428/4885 |
| US-12508226-B2 | Lipid composition | APOB, NAF1, SLC27A1 | TSHR 1216/4885THRB 1398/4885DNM1 264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.